Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults
Clinical trial NCT06669234 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06669234
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-06
- Primary completion
- 2026-07-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.